Cas:18719-22-7 1-[(4-chlorophenyl)phenylmethyl]-piperazine dihydrochloride manufacturer & supplier

Chemical Name:1-[(4-chlorophenyl)phenylmethyl]-piperazine dihydrochloride

CAS.NO:18719-22-7

Synonyms:Einecs 242-526-5;1-((4-chlorophenyl)phenylmethyl)-piperazinhydrochloride;1-[(4-chlorophenyl)benzyl]piperazine hydrochloride;1-[(4-Chlorophenyl)benzyl]piperazine dihydrochloride;norchlorcyclizinehydrochloride

Molecular Formula:C₁₇H₂₁Cl₃N₂

Molecular Weight:359.72100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:409.1ºC at 760mmHg

Density:1.158g/cm3

Index of Refraction:

PSA:15.27000

Exact Mass:358.07700

LogP:5.20530

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Einecs 242-526-5 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,norchlorcyclizinehydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[(4-chlorophenyl)benzyl]piperazine hydrochloride Use and application,norchlorcyclizinehydrochloride technical grade,usp/ep/jp grade.

Related News: As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics. 1-[(4-chlorophenyl)phenylmethyl]-piperazine dihydrochloride manufacturer With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 1-[(4-chlorophenyl)phenylmethyl]-piperazine dihydrochloride supplier In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. 1-[(4-chlorophenyl)phenylmethyl]-piperazine dihydrochloride vendor In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. 1-[(4-chlorophenyl)phenylmethyl]-piperazine dihydrochloride factory Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access.